Acquisition alignment Identify cross-sell opportunities with Bausch Health portfolio leveraging existing DURECT relationships and the accelerated access pathways within the merged entity, focusing on early-stage partnerships in pharmaceutical manufacturing and related R&D support.

Sustainability & Ops Position DURECT’s manufacturing capabilities to support Bausch Health’s expanded product lines with scalable, cost-efficient production, emphasizing quality systems, compliance, and potential for shared automation to improve margins.

Technology leverage Offer integration-ready tech stack alignment to Bausch Health operating layers (ERP, CRM, supply chain, analytics) to streamline data flows, enable joint forecasting, and accelerate time-to-market for pipeline candidates.

Growth signals capitalize on Bausch Health’s strong revenue trajectory and regional expansion to pursue channel partnerships and contract manufacturing opportunities, targeting markets where Fraxel and Solta Medical are gaining traction.

Strategic collaboration Propose co-development or licensing discussions for niche pharmaceutical formulations or delivery modalities that complement Bausch Health’s specialty pharma segment, leveraging DURECT’s development capabilities to accelerate product launches.